New Data Presented At American Burn Association's Annual Meeting Support Safety Profile Of RECOTHROM® Thrombin, Topical In Pediatric Patients
ZymoGenetics, Inc. (NASDAQ:ZGEN), today announced the presentation of safety and immunogenicity data among pediatric burn patients at the 42nd Annual Meeting of the American Burn Association in Boston, MA. The study marks the first dedicated look at the safety and immunogenicity of any stand-alone thrombin in pediatric surgical patients. The investigators concluded that RECOTHROM did not appear to be associated with any treatment-related adverse events when used as an aid to hemostasis in pediatric patients undergoing synchronous burn wound excision and skin grafting... (Source: Health News from Medical News Today)
British Medical Association Response To Announcement On Doctors' Pay
Commenting on the Health Secretary's announcement on doctors' pay, Dr Hamish Meldrum, Chairman of Council at the BMA, said: The BMA is disappointed that the government has chosen to overrule some of the recommendations of the independent pay review body. We are well aware of the financial climate in which this decision is being made, but the independent pay review body took these factors into account in coming to its recommendations... (Source: Health News from Medical News Today)
